| Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study R Thom, T Tipton, T Strecker, Y Hall, JA Bore, P Maes, FR Koundouno, ... The Lancet Infectious Diseases 21 (4), 507-516, 2021 | 34 | 2021 |
| Human diversity of killer cell immunoglobulin-like receptors and human leukocyte antigen class I alleles and Ebola virus disease outcomes T Wawina-Bokalanga, B Vanmechelen, V Lhermitte, J Martí-Carreras, ... Emerging Infectious Diseases 27 (1), 76, 2021 | 10 | 2021 |
| Plasma proteomic analysis distinguishes severity outcomes of human Ebola virus disease A Viodé, KK Smolen, B Fatou, Z Wurie, P Van Zalm, MK Konde, BM Keita, ... MBio 13 (3), e00567-22, 2022 | 4 | 2022 |
| Toward Health System Recovery in the Aftermath of Ebola Outbreak in Guinea: New Approaches for Improved Knowledge of Target Populations at the Community Level MK Konde, BM Kéita, L Massandouno, A Diallo, M Diallo, MA Toure, ... Journal of Primary Care & Community Health 13, 21501319221074470, 2022 | | 2022 |
| Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study (Oct, 10.1016/S1473-3099 (20) 30736-2, 2020) R Thom, T Tipton, T Strecker, Y Hall, JA Bore, P Maes, FR Koundouno, ... Lancet Infectious Diseases 21 (1), E1-E1, 2021 | | 2021 |
